November 15, 2013 | Lucid, Strategic planning
The benefits of including medical experts in your brand planning team
Everyone who works in pharma knows that a significant part of their year is dedicated to strategic planning. As soon as the latest five-year rolling plan is signed off, work begins on the next five years. Templates are completed and everyone loves spending days in whacky meetings talking about the great new insights you have gathered since the last planning cycle. A huge amount of time and energy is focussed on engaging the internal team. Is this one of the best opportunities you have to engage your external experts or KOLs? Could this deliver a better plan and are there other upsides of this engagement?
Why not select a team of experts and run a parallel planning process?
Immediately, I can hear anybody who has read this far mutter “we don’t have time to do this”. Lack of time is the most commonly cited reason for physicians not changing their clinical practice – even when the change will save time in the long-term because patient outcomes are better. We propose that by investing time in engaging experts in your planning, the resulting group of engaged experts will save you enormous amounts of time briefing and planning individual activities once implementation begins. (I know, you don’t actually care about this, you’ve got a new job by now!)
How might this work in practice?
Using the standard planning process, there are a number of opportunities to engage your experts. The most efficient way to do this is probably in an advisory board setting, but smaller focus groups or even structured 1:1 meetings would work.
At an advisory board or similar, you could run the following sessions:
If this can’t be done as an advisory board, consider smaller groups, covering parts of the above. You may already do some of this with a select few of your experts, but to really influence your plan, you need to do all of it with a range of experts.
Which experts should we include?
While the temptation will be to include experts that you know and that are close to your brand, if you are to see the value of this approach in delivering a better plan, you need to include a broad range of experts. For any brand, you are likely to be running some disease awareness and some differentiation activities. You need to have assessed your group of experts in terms of their ‘progressive disease management’ and their ‘brand loyalty’. Once you have done this, you can select experts from across the spectrum.
Generating true engagement
None of the above is really rocket science, nor is it too time consuming. However, the key to using this as a tool to develop better engagement of experts in your plans is to make sure you keep the dialogue open. Following the advisory board, it is critical that the advisors are contacted regularly to keep them informed about what you are doing with the information and ideas they provided and also how the actual plans are evolving. This can be done through bi-monthly webinars or, at the simplest level, via email.
I am happy with my planning process, why would I do this?
The benefits of this approach are two-fold. You can leverage the clinical insights generated by running these sessions to build a more robust and relevant plan. If you ask them for their views of the big ticket changes in the environment over the plan period you are likely to be able to sift out the really big things that will affect your plan. And if this is done in an advisory setting, you will be able to hear and assess the impact on the group as a whole, rather than get many individual viewpoints, which could be misleading.
But more important than delivering a more insightful plan is the real and lasting engagement you will have generated with this group of experts. When it comes to implementation, they will be aligned with your thinking. This will save hours in discussion as you try to agree what’s important to each of you at a later date.
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Last week, we waved goodbye to the post-holiday blues by welcoming back our legendary Thirsty Thursday sessions! Hosted by the Innovation Champions in Middlesex House, London, and broadcast to all...
The Lucid Group talent team has grown with two new Talent Acquisition Partners: Jon Turner and Ellen Field. To help you understand a bit more about them, their role, and the opportunities...
In this month’s PME, Tanya Goodyear, Director of Innovation and Transformation at Lucid Group, details Lucid’s approach to solving healthcare problems and reflects on the learnings we can draw from...
Lucid scooped a double win at this year’s Communiqué awards, the first face-to-face industry event since the start of the pandemic – making it an extra-special occasion for everyone attending....
We’re celebrating another landmark Workiversary with Richard Barry, Senior Medical Writer. Richard has now been a Lucidian for an impressive 10 years, so we thought it was only fitting to...
Summer Fridays are back, bringing some much deserved R&R for our people.☀️A ‘Summer Friday’ means that employees are now actively encouraged to finish work from 2 pm on alternate Fridays...
Since 2017, Lucid Group’s charity working group, LUCID SPIRIT, has been actively involved in helping to raise awareness and funds for its charity partners. At launch, Lucid Spirit partnered with the...
In a digitalised world, accelerated by the COVID-19 pandemic, pharmaceutical companies must work smarter to engage busy external stakeholders with endless content at their fingertipsIn this month’s edition of PME James...
Lucid Group has acquired the US-based strategic brand consultants, DiD. This union will strengthen Lucid Group’s existing presence in the US and its ability to provide a compelling strategic, creative...
Take a look at what it's like working at Lucid Group. Jack discusses his experience of Lucid's Futures Academy, of transitioning to a fully remote workforce in lockdown, Lucid's culture...
